• Explore /
  • Poster
  • / ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.

ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with/without radiotherapy in patients with newly diagnosed high-risk endometrial cancer.

Abstract Video & Slides Poster

Authors

Toon Van Gorp

Toon Van Gorp

UZ Leuven, Leuven, Belgium

Toon Van Gorp , Mansoor Raza Mirza , Alain Lortholary , David Cibula , Axel Walther , Antonella Savarese , Maria Pilar Barretina-Ginesta , Fırat Ortaç , Christos Papadimitriou , Lubomir Bodnar , Chyong-Huey Lai , Jacob Korach , Christian Marth , Kosei Hasegawa , Xing Xie , Emma L. Barber , Robert L. Coleman , Stephen Michael Keefe , Robert Orlowski , Brian Slomovitz

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Uterine Cancer

Clinical Trial Registration Number

NCT04634877

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr TPS5608)

DOI

10.1200/JCO.2021.39.15_suppl.TPS5608

Abstract #

TPS5608

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Christian Marth

First Author: Nicoletta Colombo

First Author: Kersti Oselin

First Author: Florence Joly